Stay updated on NEOMUN Trial: Anti-PD-1 in Resectable Lung Cancer
Sign up to get notified when there's something new on the NEOMUN Trial: Anti-PD-1 in Resectable Lung Cancer page.

Latest updates to the NEOMUN Trial: Anti-PD-1 in Resectable Lung Cancer page
- ChecktodayNo Change Detected
- Check7 days agoChange DetectedPage revision updated from v3.3.3 to v3.3.4; no substantive changes to the study details or content.SummaryDifference0.1%

- Check14 days agoNo Change Detected
- Check29 days agoChange DetectedFooter updates include adding Revision: v3.3.3 and removing HHS Vulnerability Disclosure and Revision: v3.3.2 from the page footer.SummaryDifference0.1%

- Check51 days agoChange DetectedRevision updated from v3.3.1 to v3.3.2, indicating a minor version bump with no visible user-facing content changes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check58 days agoChange DetectedAdded a note that PubMed publications are auto-filled and may not relate to the study, and updated the revision label from v3.2.0 to v3.3.1.SummaryDifference0.1%

- Check65 days agoChange DetectedRemoved the page-wide government funding lapse notice that previously appeared on the page. Core study details, eligibility criteria, and related content remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check79 days agoChange DetectedA Results section has been added with updated outcome measures. The Study Record Dates reflect the latest status, including Results First Posted 2025-04-04.SummaryDifference0.5%

Stay in the know with updates to NEOMUN Trial: Anti-PD-1 in Resectable Lung Cancer
Enter your email address, and we'll notify you when there's something new on the NEOMUN Trial: Anti-PD-1 in Resectable Lung Cancer page.